AVANT to Present at the BIO 2003 Annual Convention.Business Editors/Health/Medical Writers BIOWIRE2K BIO 2003 Annual Convention NEEDHAM, Mass.--(BUSINESS WIRE)--June 19, 2003 AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) announced today that it will participate in several presentations showcasing AVANT's biodefense and other vaccine strategies next week at the BIO 2003 Annual Convention in Washington, D.C., June 22-25. Included will be a Business Forum presentation where AVANT President and Chief Executive Officer, Dr. Una Ryan, will provide an overview of AVANT's programs on Tuesday, June 24, at 3:00 P.M. Eastern Time. This presentation will be available as live webcast, with replays available for approximately four weeks, through the investor information section of AVANT's website (www.avantimmune.com) or through the conference website run by BIO (www.bio.org). Dr Ryan will also participate in a Media Brunch on Sunday June 22 addressing Global Health Issues. On Tuesday, June 24, Dr. Ryan will present on Capitol Hill in a discussion entitled, "Creating a BioDefense Industry: Whether, How, What and When?" A similar panel discussion will occur on Wednesday, June 25 at the Washington Convention Center The Washington Convention Center has been the name of two convention centers in Washington, D.C. The old Washington Convention Center was located at 909 H Street NW and was in use from 1983 until 2004. . In addition, Dr. Kevin Killeen, Senior Director, Bacterial Vaccines, at AVANT, will chair a panel discussion entitled, "When is a Vaccine Safe Enough: Rotavirus rotavirus /ro·ta·vi·rus/ (ro´tah-vi?rus) any member of the genus Rotavirus. ro´taviral Rotavirus /Ro·ta·vi·rus/ (ro´tah-vi?rus vaccines as a Case Study" on Monday, June 23 at the Washington Convention Center. About BIO The Biotechnology Industry Organization Biotechnology Industry Organization or BIO was founded 1993 in Washington, DC. James C. Greenwood is BIO's current President. External links
The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. , academic institutions, state biotechnology centers and related organizations in all 50 states and 33 other nations. BIO members are involved in the research and development of health-care, agricultural, industrial and environmental biotechnology Environmental biotechnology is when biotechnology is applied to and used to study the natural environment. Environmental biotechnology could also imply that one try to harness biological process for commercial uses and exploitation. products. Dr. Ryan is a member of the Board of Directors of BIO. About AVANT AVANT Immunotherapeutics, Inc. is engaged in the discovery, development and commercialization of products that harness the human immune system immune system Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders. to prevent and treat disease. The company is developing a broad portfolio of vaccines addressing a wide range of applications including bacterial and viral diseases viral diseases Diseases caused by viruses. Long-term immunity usually follows viral childhood diseases (see chickenpox). The common cold recurs into adulthood because many different viruses cause its symptoms, and immunity against one does not protect against others. , chronic human disease, biodefense and food safety. These include single-dose, oral vaccines that protect against important disease-causing agents and a novel, proprietary vaccine candidate for cholesterol management. AVANT's goal is to demonstrate proof-of-concept for its products before leveraging their value through partnerships. Current collaborations encompass the development of an oral human rotavirus vaccine, vaccines to combat threats of biological warfare biological warfare, employment in war of microorganisms to injure or destroy people, animals, or crops; also called germ or bacteriological warfare. Limited attempts have been made in the past to spread disease among the enemy; e.g. , and vaccines addressed to human food safety and animal health. Additional information on AVANT Immunotherapeutics, Inc. can be obtained through our site on the World Wide Web: http://www.avantimmune.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion